Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.

about

Complex neuroprotective and neurotoxic effects of histone deacetylases.

P2860

Q49884282-94FE8030-0ED3-4527-AF3F-25C2225A7E29

P2860

Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.

Item

http://www.wikidata.org/entity/Q45302345

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.

@en

Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.

@nl

type

Item

label

Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.

@en

Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.

@nl

prefLabel

Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.

@en

Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.

@nl

P1476

Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.

@en

P2093

Doris Kretzschmar

http://www.w3.org/2001/XMLSchema#string

Elizabeth Thomas

http://www.w3.org/2001/XMLSchema#string

Santosh R D'Mello

http://www.w3.org/2001/XMLSchema#string

Tanzeen Yusuff

http://www.w3.org/2001/XMLSchema#string

P2860

De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment

BEHAVIORAL MUTANTS OF Drosophila ISOLATED BY COUNTERCURRENT DISTRIBUTION

The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice.

FoxP1 orchestration of ASD-relevant signaling pathways in the striatum.

Targeted gene expression as a means of altering cell fates and generating dominant phenotypes

Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder

Phosphorylation of arfaptin 2 at Ser260 by Akt Inhibits PolyQ-huntingtin-induced toxicity by rescuing proteasome impairment

Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease

Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation

Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3beta

P304

6575-6587

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1523/JNEUROSCI.3612-16.2017

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marlène Cassar

A S C Louis Sam Titus

Marlène Cassar

P577

2017-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28550168

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

5511885

http://www.w3.org/2001/XMLSchema#string

Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.

about

P2860

P2860

Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932